The Journal of Allergy and Clinical Immunology
Volume 117, Issue 1 , Pages 45-52 , January 2006

Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma

  • Robert S. Zeiger, MD, PhD

      Affiliations

    • From the Department of Pediatrics, University of California-San Diego
    • Department of Allergy, Kaiser Permanente San Diego
    • Corresponding Author InformationReprint requests: Robert S. Zeiger, MD, PhD, University of California, San Diego, Department of Pediatrics, and Kaiser Permanente, San Diego, Department of Allergy, 7060 Clairemont Mesa Blvd, San Diego, CA 92111.
    • ,
  • Stanley J. Szefler, MD

      Affiliations

    • Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver
    • ,
  • Brenda R. Phillips, MS

      Affiliations

    • Department of Health Evaluation Sciences, Pennsylvania State University, Hershey
    • ,
  • Michael Schatz, MD, MS

      Affiliations

    • Department of Allergy, Kaiser Permanente San Diego
    • ,
  • Fernando D. Martinez, MD

      Affiliations

    • Arizona Respiratory Center, University of Arizona, Tucson
    • ,
  • Vernon M. Chinchilli, PhD

      Affiliations

    • Department of Health Evaluation Sciences, Pennsylvania State University, Hershey
    • ,
  • Robert F. Lemanske Jr., MD

      Affiliations

    • Clinical Science Center, University of Wisconsin, Madison
    • ,
  • Robert C. Strunk, MD

      Affiliations

    • Department of Pediatrics, Washington University, St Louis
    • ,
  • Gary Larsen, MD

      Affiliations

    • Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver
    • ,
  • Joseph D. Spahn, MD

      Affiliations

    • Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver
    • ,
  • Leonard B. Bacharier, MD

      Affiliations

    • Department of Pediatrics, Washington University, St Louis
    • ,
  • Gordon R. Bloomberg, MD

      Affiliations

    • Department of Pediatrics, Washington University, St Louis
    • ,
  • Theresa W. Guilbert, MD

      Affiliations

    • Arizona Respiratory Center, University of Arizona, Tucson
    • ,
  • Gregory Heldt, MD

      Affiliations

    • From the Department of Pediatrics, University of California-San Diego
    • ,
  • Wayne J. Morgan, MD

      Affiliations

    • Arizona Respiratory Center, University of Arizona, Tucson
    • ,
  • Mark H. Moss, MD

      Affiliations

    • Clinical Science Center, University of Wisconsin, Madison
    • ,
  • Christine A. Sorkness, PharmD

      Affiliations

    • Clinical Science Center, University of Wisconsin, Madison
    • ,
  • Lynn M. Taussig, MD

      Affiliations

    • Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver
    • ,
  • for the Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute

      Affiliations

    • See Appendix E1 in the Online Repository of this article at www.jacionline.org for members of the Childhood Asthma Research and Education (CARE) Network involved in this study. The members of the Writing Committee were R. Zeiger (Chair), S. Szefler, B. Phillips, V. Chinchilli, R. Lemanske, F. Martinez, R. Strunk, M. Schatz, and G. Larsen.

Received 24 August 2005 ,Revised 3 October 2005 ,Accepted 5 October 2005.

References 

  1. National Asthma Education and Prevention Program . Expert panel report: guidelines for the diagnosis and management of asthma update on selected topics—2002. J Allergy Clin Immunol. 2002;110(suppl):S141–S219
  2. The Global Initiative for Asthma. Bethesda (MD): US Department of Health and Human Services Public Health Service, NIH, NHLBI; 2002;NIH Publication no. 02-3659
  3. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB, et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol. 2004;114:40–47
  4. Childhood Asthma Management Program (CAMP) Research Group . long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 2000;343:1054–1063
  5. Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA. 1998;279:1181–1186
  6. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med. 1999;130:487–495
  7. Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ. 2003;326:621–625
  8. Ducharme FM. Inhaled corticosteroids versus leukotriene antagonists as first-line therapy for asthma: a systematic review of current evidence. Treat Respir Med. 2004;3:399–405
  9. Maspero JF, Duenas-Meza E, Volovitz B, Pinacho DC, Kosa L, Vrijens F, et al. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin. 2001;17:96–104
  10. Stelmach I, Jerzynska J, Kuna P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy. 2002;32:264–269
  11. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, et al. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol. 2005;115:233–242
  12. Zhang J, Yu C, Holgate ST, Reiss TF. Variability and lack of predictive ability of asthma end-points in clinical trials. Eur Respir J. 2002;20:1102–1109
  13. Strunk RC, Szefler SJ, Phillips BR, Zeiger RS, Chinchilli VM, Larsen G, et al. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children. J Allergy Clin Immunol. 2003;112:883–892
  14. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE. Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis. 1991;143:1317–1321
  15. Gershman NH, Wong HH, Liu JT, Fahy JV. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment. Eur Respir J. 2000;15:11–18
  16. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am J Respir Crit Care Med. 1999;160:1862–1868
  17. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999;14:902–907
  18. Kissoon N, Duckworth L, Blake K, Murphy S, Silkoff PE. Exhaled nitric oxide measurements in childhood asthma: techniques and interpretation. Pediatr Pulmonol. 1999;28:282–296
  19. American Thoracic Society . Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152:1107–1136
  20. Goldman MD, Carter R, Klein R, Fritz G, Carter B, Pachucki P. Within- and between-day variability of respiratory impedance, using impulse oscillometry in adolescent asthmatics. Pediatr Pulmonol. 2002;34:312–319
  21. Marotta A, Klinnert MD, Price MR, Larsen GL, Liu AH. Impulse oscillometry provides an effective measure of lung dysfunction in 4-year-old children at risk for persistent asthma. J Allergy Clin Immunol. 2003;112:317–322
  22. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics. 1989;45:255–268
  23. Stempel DA, Fuhlbrigge AL. Defining the responder in asthma therapy. J Allergy Clin Immunol. 2005;115:466–469
  24. Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics. 2005;116:360–369
  25. Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza R, et al. Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr. 2005;147:213–220
  26. Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, et al. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am J Med. 2005;118:649–657
  27. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410–418
  28. Shingo S, Zhang J, Reiss TF. Correlation of airway obstruction and patient-reported endpoints in clinical studies. Eur Respir J. 2001;17:220–224
  29. Meyer KA, Arduino JM, Santanello NC, Knorr BA, Bisgaard H. Response to montelukast among subgroups of children aged 2 to 14 years with asthma. J Allergy Clin Immunol. 2003;111:757–762
  30. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158:1213–1220
  31. Malmberg LP. Exhaled nitric oxide in childhood asthma—time to use inflammometry rather than spirometry?. J Asthma. 2004;41:511–520
  32. Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol. 2005;115:953–959
  33. Wilson AM, Orr LC, Sims EJ, Dempsey OJ, Lipworth BJ. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med. 2000;162:1297–1301
  34. Dempsey OJ, Kennedy G, Lipworth BJ. Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with mild persistent asthma. J Allergy Clin Immunol. 2002;109:68–74
  35. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352:1519–1528
  36. Carra S, Gagliardi L, Zanconato S, Scollo M, Azzolin N, Zacchello F, et al. Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children. Respir Med. 2001;95:734–739
  37. Mondino C, Ciabattoni G, Koch P, Pistelli R, Trove A, Barnes PJ, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol. 2004;114:761–767
  38. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med. 1999;160:1227–1231
  39. Buchvald F, Baraldi E, Carraro S, Gaston B, De JJ, Pijnenburg MW, et al. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol. 2005;115:1130–1136
  40. Jones SL, Kittelson J, Cowan JO, Flannery EM, Hancox RJ, McLachlan CR, et al. The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control. Am J Respir Crit Care Med. 2001;164:738–743
  41. Smith AD, Cowan JO, Brassett KP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172:453–459

 Supported by grants 5U10HL064287, 5U10HL064288, 5U10HL064295, 5U10HL064307, 5U10HL064305, and 5U10HL064313 from the National Heart, Lung, and Blood Institute. This study was carried out in part in the General Clinical Research Centers at Washington University School of Medicine (M01 RR00036) and National Jewish Medical and Research Center (M01 RR00051).

 Disclosure of potential conflict of interest: R. Zeiger has consultant arrangements with AstraZeneca, Genentech, GlaxoSmithKline, and Novartis and has received grants from AstraZeneca, Aventis, GlaxoSmithKline, and Merck. S. Szefler has consultant arrangements with AstraZeneca, Aventis, GlaxoSmithKline, and Merck and has received grants from the National Heart, Lung, and Blood Institute (NHLBI) Childhood Asthma Research and Education (CARE) network and AstraZeneca. M Schatz has received grants from GlaxoSmithKline and Sanofi-Aventis and is on the speakers' bureau for AstraZeneca and Merck. F. Martinez is on the advisory board for Merck, Genentech, and Altana Pharma; has patent licensing arrangements with Wisconsin Alumni Research Foundation; and is on the speakers' bureau for AstraZeneca. V. Chinchilli has consultant arrangements with Pfizer, Eli Lilly, and Insmed and has received grants from the NHLBI CARE Network. R. Lemanske has consultant arrangements with AstraZeneca, Aventis, GlaxoSmithKline, and Novartis/Genentech; has received grants from the NHLBI and the National Institute of Allergy and Infectious Diseases (NIAID); and is on the speakers' bureau for Merck, GlaxoSmithKline, and AstraZeneca. G. Larsen is on the advisory board for GlaxoSmithKline and Schering-Plough. J. Spahn has consultant arrangements with GlaxoSmithKline, has received grants from Merck, and is on the speakers' bureau for GlaxoSmithKline. L. Bacharier has received grants from the NHLBI and is on the speakers' bureau for GlaxoSmithKline, Merck, Genentech, and AstraZeneca. T. Guilbert has consultant arrangements with GlaxoSmithKline; has received grants from GlaxoSmithKline and Genentech; is on the speakers' bureau for GlaxoSmithKline, AstraZeneca, Soma Medical Education, Innovia Education Institute, Antidote; and is part of the Exchange Program Steering Committee that designs CMEs. C. Sorkness has consultant arrangements with GlaxoSmithKline and AstraZeneca, has received grants from GlaxoSmithKline, and is on the speakers' bureau for GlaxoSmithKline, AstraZeneca, and Genentech. L. Taussig has consultant arrangements with GlaxoSmithKline.

PII: S0091-6749(05)02267-0

doi: 10.1016/j.jaci.2005.10.012

The Journal of Allergy and Clinical Immunology
Volume 117, Issue 1 , Pages 45-52 , January 2006

Article Tools

* Image Usage & Resolution